ArticleFrontiers in oncology2025
Retrospective assessment of the frequency of cancer in the population of kidney transplant recipients - the experience of two transplant centers.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cancer is one of the main causes of death among kidney recipients. The risk of cancer in kidney transplant recipients (KTRs) is 2-3 times higher as compared to the general population. Aim: Retrospective assessment of the occurrence of cancer in the population of KTRs - based on data from two transplant centers. Material: The study included a total of 246 KTRs, transplanted between 1980 and 2021, who were diagnosed with malignancy (the study did not include patients whose only cancer was non-melanoma skin cancer; NMSC). Results: 261 malignant tumors were diagnosed in 246 KTRs, 3 tumor was a recurrence, and the rest occurred Conclusions: Similarly to the general population, the most common cancers among KTRs included breast and prostate cancer, as well as colorectal and lung cancer. Attention should be paid to the extremely frequent occurrence of native kidney and lymphatic system cancers in this group of KTRs. The frequent occurrence of cancer in KTRs requires systematic screening in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.